Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
PART 05: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 06: Impact of regulatory services
- Impact of regulatory services on clinical diagnostic devices
PART 07: Clinical diagnostics: Product pipeline
- Clinical diagnostics: Product pipeline
PART 08: Market segmentation by product
- Immunodiagnostics market in APAC
- POC diagnostics market in APAC
- Molecular diagnostics market in APAC
- Hematology devices market in APAC
- Tissue diagnostics market in APAC
- Clinical microbiology systems market in APAC
PART 09: Market drivers
- Early and accurate diagnosis of life-threatening diseases
- Market expansion
- POC home diagnostics
- Government funding
- Domestic manufacturing of devices in China
PART 10: Impact of drivers
PART 11: Market challenges
- Lack of infrastructure and skilled professionals
- Issues with intellectual property rights
- Availability of counterfeit IVD products
- Inaccuracy of conventional diagnostics
- Pricing policies and unfavorable reimbursement policies in China
PART 12: Impact of drivers and challenges
PART 13: Market trends
- Privatization and healthcare coverage
- Emergence of antibiotic-resistant pathogens
- Personalized medicines
- Next-generation technology and DNA microarrays
- Local distributors as intermediaries
PART 14: Vendor landscape
- Competitive scenario
- Market share analysis 2014
- Other prominent vendors
- PART 15: Key vendor analysis
- Abbott Diagnostics
- bioMérieux
- Beckman Coulter
- Qiagen
- Roche Diagnostics
PART 16: Appendix
PART 17: Explore Technavio
Get the report (PDF) sent to your email within minutes.